Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Gepotidacin	314
Overall Study	STARTED	Ceftriaxone Plus Azithromycin	314
Overall Study	Safety Population	Gepotidacin	309
Overall Study	Safety Population	Ceftriaxone Plus Azithromycin	313
Overall Study	Microbiological ITT (Micro-ITT) Population	Gepotidacin	202
Overall Study	Microbiological ITT (Micro-ITT) Population	Ceftriaxone Plus Azithromycin	204
Overall Study	Micro-ITT Rectal Population	Gepotidacin	26
Overall Study	Micro-ITT Rectal Population	Ceftriaxone Plus Azithromycin	15
Overall Study	Micro-ITT Pharyngeal Population	Gepotidacin	18
Overall Study	Micro-ITT Pharyngeal Population	Ceftriaxone Plus Azithromycin	17
Overall Study	COMPLETED	Gepotidacin	294
Overall Study	COMPLETED	Ceftriaxone Plus Azithromycin	295
Overall Study	NOT COMPLETED	Gepotidacin	20
Overall Study	NOT COMPLETED	Ceftriaxone Plus Azithromycin	19

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04010539/flow